by | Jan 30, 2024 | Myeloma News
Source: Pharmacy Times articles Experts describe considerations for selecting appropriate patients for treatment with a bispecific antibody, including prior therapies for relapsed or refractory multiple myeloma. Strategies to quickly prepare patients for treatment...
by | Jan 29, 2024 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
by | Jan 24, 2024 | Myeloma News
Source: Pharmacy Times articles Gabriel Hinojosa, PharmD, BCOP, provides insights on selecting the best treatment regimen, and considers comorbidities, adverse events, and therapy modifications in multiple myeloma treatment. Read More
by | Jan 23, 2024 | Myeloma News
Source: Pharmacy Times articles Data support the quadruplet regimen as a new standard of care for transplant-eligible patients. Read More
by | Jan 22, 2024 | Myeloma News
Source: Pharmacy Times articles There is a significant efficacy-effectiveness gap in standard-of-care regimens. Read More
by | Jan 22, 2024 | Myeloma News
Source: Pharmacy Times articles Experts discuss the impact of advances in the treatment of multiple myeloma on patient care. Read More
